Published on
20/08/2026 - 16:08 GMT+2
The Democratic Republic of the Congo is set to receive 70,000 doses of the Ervebo vaccine, which has proven effective in previous Ebola outbreaks, the World Health Organisation (WHO) and its partners said on Thursday.
The WHO said in a statement that while it’s not known whether Ervebo may protect against the Bundibugyo strain of the virus, “early laboratory and animal data suggest it may provide some protection.”
Ervebo is approved against the more common Zaire strain of Ebola, but not against the Bundibugyo strain driving the current outbreak.










